Richard Lopez, MD, Oncology, Durham, NC, Duke University Hospital

RichardDLopezMD

Oncology Durham, NC

Assoc. Prof. Medicine (Hem/Onc; BMT)

Dr. Lopez is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lopez's full profile

Already have an account?

Education & Training

  • Stanford University
    Stanford UniversityInternship, Internal Medicine, 1989 - 1990
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1989

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2013 - 2022
  • AL State Medical License
    AL State Medical License 1999 - 2013
  • GA State Medical License
    GA State Medical License 1996 - 1999
  • CA State Medical License
    CA State Medical License 1991 - Present
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

Abstracts/Posters

  • Daily Chlorhexidine Gluconate Bathing Reduces the Rate of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Stem Cell Transplantation
    Richard D. Lopez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell Transplantation
    Richard D. Lopez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...
    Richard D. Lopez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Grant Support

  • Therapeutic Antitumor And Antiviral Potential Of Allogeneic Gamma-Delta T CellsNational Institute Of Allergy And Infectious Diseases2010–2011
  • Gamma Delta T Cell Immunotherapy Of Breast CancerNational Cancer Institute2007–2011
  • Gamma Delta T Cells--Immunotherapy For MelanomaNational Cancer Institute2002–2004

Hospital Affiliations